Skip to content

Longitudinal and Biological Study of Childhood Disintegrative Disorder

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00004458
Enrollment
220
Registered
1999-10-19
Start date
1997-05-31
Completion date
Unknown
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism, Pervasive Child Development Disorders

Keywords

autism, childhood disintegrative disorder, neurologic and psychiatric disorders, rare disease

Brief summary

OBJECTIVES: I. Compare the developmental course (language acquisition, diagnostic stability, predictors of outcome, and restricted interests and behaviors) of childhood disintegrative disorder versus autism and non-autistic developmental delays. II. Collect data on molecular genetics of proband and family members.

Detailed description

PROTOCOL OUTLINE: Patients are evaluated with the following questionnaires at ages 2-3 years and again at ages 5-9: The Autism Diagnostic Interview (ADI); The Autism Diagnostic Observation Schedule (ADOS); Assessment of cognitive functioning; Expressive and receptive language; Adaptive functioning; Measures of burden and functional assessment; The Aberrant Behavior Checklist; The Connors Rating Scale - Parent and Teacher version; and Autism Behavior Checklist An MRI and EEG are performed, and blood samples are collected from patients and family members for molecular genetic studies.

Interventions

None listed

Sponsors

Yale University
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Lead SponsorNIH

Study design

Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
2 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

* Psychologically diagnosed (DSM-IV) as Childhood Disintegrative Disorder * No known genetic or medical syndrome (Down syndrome or cerebral palsy) * Must speak English

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026